New Jersey S4210 revises telehealth and telemedicine requirements for adult prescriptions of Schedule II drugs for ADHD treatment.

New Jersey S4210 amends existing law to modify telehealth and telemedicine requirements for prescribing Schedule II drugs to adults for attention-deficit/hyperactivity disorder (ADHD) treatment. The bill allows health care providers to prescribe these drugs via telemedicine or telehealth after an initial in-person examination, with subsequent in-person visits required every six months. It also mandates that health care providers maintain the same standard of care for telemedicine and telehealth services as for in-person services. The bill does not alter current requirements for minor patients.

New Jersey S4210 revises telehealth and telemedicine requirements for adult prescriptions of Schedule II drugs for ADHD treatment.

New Jersey S4210 amends existing law to modify telehealth and telemedicine requirements for prescribing Schedule II drugs to adults for attention-deficit/hyperactivity disorder (ADHD) treatment. The bill allows health care providers to prescribe these drugs via telemedicine or telehealth after an initial in-person examination, with subsequent in-person visits required every six months. It also mandates that health care providers maintain the same standard of care for telemedicine and telehealth services as for in-person services. The bill does not alter current requirements for minor patients.